UMIN ID: UMIN000001035
Registered date:15/02/2008
Therapeutic efficacy of Pioglitazone for Non-Alcoholic Fatty Liver Desease(NAFLD) patients with impaired glucose tolerance or type 2 diabetes
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Non-Alcoholic Fatty Liver Disease |
| Date of first enrollment | 2008/01/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Administration of pioglitazone Administration of diabetic medicine except for pioglitazone and metformin |
Outcome(s)
| Primary Outcome | NASH activity score |
|---|---|
| Secondary Outcome | Fibrosis of liver |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients who did not consent to enroll to the study Patients with contraindication for pioglitazone Patients with malignant disease Others who are not suitable to enroll to the study from the physicians points of view |
Related Information
| Primary Sponsor | Tohoku University Graduate School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Futoshi Nagasaki |
| Address | 3-1 Shimizu-Kouji Wakabayashi-ku Sendai city Miyagi prefecture Japan Japan |
| Telephone | 022-266-7111 |
| fnagasaki@int3.med.tohoku.ac.jp | |
| Affiliation | Sendai City Hospital Gastroenterology |
| scientific contact | |
| Name | Tooru Shimosegawa |
| Address | 1-1 Seiryou-machi Aoba-ku Sendai-city Miyagi-prefecture Japan Japan |
| Telephone | 022-717-7171 |
| Affiliation | Tohoku University Graduate School of Medicine Gastroenterology |